603392.SS

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. [603392.SS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

603392.SS Stock Summary

Top 10 Correlated ETFs

603392.SS


Top 10 Correlated Stocks

603392.SS


In the News

603392.SS Financial details

Company Rating
Buy
Market Cap
94.8B
Income
2.6B
Revenue
7.5B
Book val./share
10.62
Cash/share
4.56
Dividend
1
Dividend %
1.3%
Employees
4.02K
Optionable
No
Shortable
Yes
Earnings
29 Mar 2024
P/E
23.75
Forward P/E
12.79
PEG
2.38
P/S
12.11
P/B
4.64
P/C
15.23
P/FCF
38.06
Quick Ratio
3.53
Current Ratio
3.99
Debt / Equity
0.02
LT Debt / Equity
0.01
-
-
EPS (TTM)
3.27
EPS next Y
5.43
EPS next Q
-
EPS this Y
223.78%
EPS next Y
65.72%
EPS next 5Y
65.72%
EPS last 5Y
81.45%
Revenue last 5Y
62.65%
Revenue Q/Q
-36.94%
EPS Q/Q
-83.61%
-
-
-
-
SMA20
4.35%
SMA50
-7.69%
SMA100
67.44%
Inst Own
-
Inst Trans
-
ROA
16%
ROE
20%
ROC
0.21%
Gross Margin
89%
Oper. Margin
39%
Profit Margin
35%
Payout
35%
Shs Outstand
1.26B
Shs Float
222.93M
-
-
-
-
Target Price
-
52W Range
40.14-88.0
52W High
-21.09%
52W Low
+73.6%
RSI
47
Rel Volume
0.36
Avg Volume
16.33M
Volume
5.93M
Perf Week
-4.81%
Perf Month
12.97%
Perf Quarter
-
Perf Half Y
43.71%
-
-
-
-
Beta
2.169
-
-
Volatility
2.45%, 4.29%
Prev Close
1.98%
Price
69.44
Change
-2.17%

603392.SS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.921.081.974.6712.54
Net income per share
0.270.190.571.645.31
Operating cash flow per share
0.20.250.391.374.63
Free cash flow per share
-0.040.10.070.523.59
Cash per share
0.40.310.641.188.07
Book value per share
1.261.422.143.6313.84
Tangible book value per share
1.051.221.963.4713.72
Share holders equity per share
1.261.422.143.6313.84
Interest debt per share
0.03-0.090.080.240.32
Market cap
4.73B4.87B84.74B134.25B80.71B
Enterprise value
4.32B4.61B84.11B133.12B75.8B
P/E ratio
16.1423.31125.1766.4117.04
Price to sales ratio
4.814.1135.9923.357.22
POCF ratio
22.7117.86180.9979.8219.53
PFCF ratio
-125.27441.09K211.725.2
P/B Ratio
3.53.1233.1830.066.54
PTB ratio
3.53.1233.1830.066.54
EV to sales
4.43.8935.7323.156.78
Enterprise value over EBITDA
17.0914.2893.2652.2512.98
EV to operating cash flow
20.7616.9179.6479.1518.34
EV to free cash flow
-114.5241.631.08K209.9223.67
Earnings yield
0.060.040.010.020.06
Free cash flow yield
-0.010.02000.04
Debt to equity
0.02-0.060.040.060.02
Debt to assets
0.01-0.050.030.040.02
Net debt to EBITDA
-1.6-0.81-0.7-0.44-0.84
Current ratio
2.531.82.391.963.49
Interest coverage
47.87209.7459.83409.14729.63
Income quality
0.711.30.690.810.85
Dividend Yield
00000
Payout ratio
0.02000.060.03
Sales general and administrative to revenue
0.030.020.010.010
Research and developement to revenue
0.140.140.130.120.1
Intangibles to total assets
0.140.110.070.040.02
Capex to operating cash flow
-1.18-0.59-0.83-0.62-0.23
Capex to revenue
-0.25-0.14-0.17-0.18-0.08
Capex to depreciation
-3.46-2.01-4.62-9.95-6.12
Stock based compensation to revenue
00.03-0.0200
Graham number
2.792.465.2211.5840.66
ROIC
0.210.150.260.440.39
Return on tangible assets
0.190.110.210.30.3
Graham Net
0.240.080.50.847.82
Working capital
526.29M393.63M1.15B2.28B8.69B
Tangible asset value
1.12B1.34B2.35B4.27B12.23B
Net current asset value
426.35M301.47M1.05B2.16B8.52B
Invested capital
0.02-0.060.040.060.02
Average receivables
210.36M248.23M517.7M1.55B3.18B
Average payables
80.54M79.74M98.89M153.1M272.63M
Average inventory
198.67M227.54M318.24M496.6M731.15M
Days sales outstanding
78.6687.79116.39149.44130.64
Days payables outstanding
100.9793.8293.0786.35109.71
Days of inventory on hand
296.58260.83330.24264.77271.05
Receivables turnover
4.644.163.142.442.79
Payables turnover
3.613.893.924.233.33
Inventory turnover
1.231.41.111.381.35
ROE
0.220.130.270.450.38
Capex per share
-0.23-0.15-0.33-0.85-1.04

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
2.982.783.21.420.64
Net income per share
1.370.871.380.510.08
Operating cash flow per share
1.370.871.380.530.58
Free cash flow per share
0.920.880.940.290.37
Cash per share
7.267.97.196.574.56
Book value per share
12.6713.5415.0614.6310.62
Tangible book value per share
12.0513.4214.8814.1710.28
Share holders equity per share
12.6713.5415.0614.6310.62
Interest debt per share
0.140.310.340.310.22
Market cap
74.49B82.5B74.84B60.23B60.12B
Enterprise value
69.95B77.58B70.77B56.8B56.72B
P/E ratio
14.8926.0415.0332.92141.78
Price to sales ratio
27.3832.5525.9347.1774.66
POCF ratio
59.55104.1760.12125.5482.92
PFCF ratio
88.88102.3887.88227.17129.07
P/B Ratio
6.456.685.514.564.52
PTB ratio
6.456.685.514.564.52
EV to sales
25.7130.6124.5244.4870.44
Enterprise value over EBITDA
47.8690.9546.82114.691.58K
EV to operating cash flow
55.9297.9656.85118.3878.25
EV to free cash flow
83.4796.2883.1214.22121.79
Earnings yield
0.020.010.020.010
Free cash flow yield
0.010.010.0100.01
Debt to equity
0.010.020.020.020.02
Debt to assets
0.010.020.020.020.02
Net debt to EBITDA
-3.11-5.76-2.69-6.94-94.29
Current ratio
3.513.493.944.143.99
Interest coverage
1.43K467.97709.34265.8934.63
Income quality
1111.056.84
Dividend Yield
0000.010
Payout ratio
0001.940.18
Sales general and administrative to revenue
0.05-0.040.02-0.030.22
Research and developement to revenue
0.050.280.080.190.43
Intangibles to total assets
0.050.020.020.040.04
Capex to operating cash flow
-0.330.02-0.32-0.45-0.36
Capex to revenue
-0.150.01-0.14-0.17-0.32
Capex to depreciation
-8.860.3-3.42-1.872.53
Stock based compensation to revenue
0000-0.01
Graham number
19.7816.2721.6212.924.5
ROIC
0.110.070.090.030.01
Return on tangible assets
0.090.050.070.030.01
Graham Net
7.357.658.227.75.06
Working capital
8.33B8.69B9.64B9.09B8.27B
Tangible asset value
10.99B12.23B13.42B12.79B12.88B
Net current asset value
8.17B8.52B9.44B8.9B8.06B
Invested capital
0.010.020.020.020.02
Average receivables
4.21B4.13B4.6B4.98B4.39B
Average payables
257.92M295.37M344.27M322.2M308.09M
Average inventory
699.15M793.43M936.39M1.04B1.1B
Days sales outstanding
140.83142.15162.25334.5451.08
Days payables outstanding
82.24117.9125.1169.07149.6
Days of inventory on hand
247.03291.26372.86594.86543.88
Receivables turnover
0.640.630.550.270.2
Payables turnover
1.090.760.720.530.6
Inventory turnover
0.360.310.240.150.17
ROE
0.110.060.090.030.01
Capex per share
-0.450.02-0.44-0.24-0.21

603392.SS Frequently Asked Questions

What is Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. stock symbol ?

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a CN stock and trading under the symbol 603392.SS

What is Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. stock quote today ?

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. stock price is $69.44 today.

Is Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. stock public?

Yes, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Similar Market Cap